NanoLogix rapid TB detection results published in Journal of Microbial & Biochemical Technology

Hubbard, OH -December 17, 2012 -- NanoLogix (OTC Markets: NNLX) An independent third-party study by one of the foremost Biomedical Research centers in the U.S has demonstrated that NanoLogix's BioNanoPore (BNP) Ultra-Fast Identification Technology enables detection of live Tuberculosis cultures in five days as opposed to two+ weeks with traditional methods.